Christoph Rader
- Molecular Biology top 1%
- Oncology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Immunology top 1%
- Biomedical Engineering top 2%
- Co-authors
- Carlos F. BarbasStanley R. RiddellMichael HudecekHaiyong PengPaula L. KosasihDaniel SommermeyerMichael C. JensenMikhail Popkov
- Topics
- Monoclonal and Polyclonal Antibodies Research (103 papers)Glycosylation and Glycoproteins Research (38 papers)CAR-T cell therapy research (36 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Christoph Rader
175 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 4.1k
- Oncology 3.1k
- Radiology, Nuclear Medicine and Imaging 2.4k
- Immunology 1.7k
- Biomedical Engineering 1.1k
Countries citing papers authored by Christoph Rader
This map shows the geographic impact of Christoph Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Rader more than expected).
Fields of papers citing papers by Christoph Rader
This network shows the impact of papers produced by Christoph Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Rader. The network helps show where Christoph Rader may publish in the future.
Co-authorship network of co-authors of Christoph Rader
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Rader. A scholar is included among the top collaborators of Christoph Rader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Rader. Christoph Rader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 34 | |
| 5 | 9 | |
| 6 | 21 | |
| 7 | 22 | |
| 8 | SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivitybreakdown → | 662 |
| 9 | 15 | |
| 10 | 62 | |
| 11 | 37 | |
| 12 | 33 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 12 | |
| 16 | 139 | |
| 17 | The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activitybreakdown → | 406 |
| 18 | 424 | |
| 19 | 145 | |
| 20 | 54 |
About Christoph Rader
Christoph Rader is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Genetics, having authored 180 papers that have together received 8.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (103 papers), Glycosylation and Glycoproteins Research (38 papers) and CAR-T cell therapy research (36 papers). The work is most often cited by research in Oncology (3.1k citations), Radiology, Nuclear Medicine and Imaging (2.4k citations) and Developmental Neuroscience (370 citations). Christoph Rader has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Carlos F. Barbas, Stanley R. Riddell, Michael Hudecek, Haiyong Peng, Paula L. Kosasih, Daniel Sommermeyer, Michael C. Jensen, Mikhail Popkov, P. Sonderegger and Sivasubramanian Baskar. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.